We have observed
6 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Long rigid spacers to enhance binding kinetics in immunoassays
Robust variant identification and validation
Particle repulsion to enhance surface contact in magnetic particle immunoassays
Tamper-proof genetic sequence processing
Magnetically assisted processing of a medium
Outside clinical monitoring apparatus for monitoring a person